Third Booster COVID-19 Vaccine Shot Available by Fall: Moderna
While not required, a third booster shot could provide additional protection against COVID-19 variants
Infectious Disease
Risk for Subsequent SARS-CoV-2 Infection Lower With Seropositivity
Among healthy, young adults, risk for subsequent infection among seropositive participants about one-fifth of that for seronegative participants
Bamlanivimab Monotherapy No Longer Authorized for COVID-19 Treatment
Alternative authorized monoclonal antibody therapies remain available for the treatment of COVID-19.
COVID-19 Virus Spike Protein Detected in Urine
In a small study, 25% of adults with COVID-19 shed SARS-CoV-2 spike S1 protein in their urine at least once during the course of infection.
Booster Shots a Likely Reality for COVID-19-Vaccinated Americans
And, CDC has scheduled a new emergency hearing on the safety of J&J vaccine for April 23
Real-World Data Show Tdap Vaccination During Pregnancy Reduces Infant Pertussis Risk
Tdap vaccination in the recommended 27–36-week window provides the largest benefit.
Thousands of Vaccinated People in US Infected With COVID-19
New data are the first to indicate how effective COVID-19 vaccines are in real life.
MPR Weekly Dose Podcast 75
The latest status on the Janssen vaccine; Updated guidance from the National Institutes of Health on COVID-19 antibody treatment; The FDA changes in-person mifepristone dispensing; A prefilled-syringe for Xolair injection is approved; And the AI world comes to colonoscopies.
Mixed Results for Ciclesonide Metered-Dose Inhaler in COVID-19 Study
The multicenter, randomized, double-blind, placebo-controlled study included 400 patients with symptomatic COVID-19 infection.
Merck Halts Molnupiravir Trial in Hospitalized COVID-19 Patients; Outpatient Study to Continue
MOVe-OUT is a placebo-controlled, double-blind phase 2/3 study investigating the efficacy and safety of molnupiravir in non-hospitalized patients.
